WVE

Wave Life Sciences (WVE)

Wave Life Sciences Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:WVE

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/25	20:30	GlobeNewswire Inc.	Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington’s Disease	NASDAQ:WVE	Wave Life Sciences Ltd
2024/06/12	21:30	GlobeNewswire Inc.	Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing	NASDAQ:WVE	Wave Life Sciences Ltd
2024/05/30	21:30	GlobeNewswire Inc.	Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference	NASDAQ:WVE	Wave Life Sciences Ltd
2024/05/10	20:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:WVE	Wave Life Sciences Ltd
2024/05/09	20:37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WVE	Wave Life Sciences Ltd
2024/05/09	20:30	GlobeNewswire Inc.	Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:WVE	Wave Life Sciences Ltd
2024/05/09	20:00	GlobeNewswire Inc.	Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer	NASDAQ:WVE	Wave Life Sciences Ltd
2024/05/07	21:30	GlobeNewswire Inc.	Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference	NASDAQ:WVE	Wave Life Sciences Ltd
2024/05/02	21:30	GlobeNewswire Inc.	Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024	NASDAQ:WVE	Wave Life Sciences Ltd
2024/04/30	21:30	GlobeNewswire Inc.	Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)	NASDAQ:WVE	Wave Life Sciences Ltd
2024/04/23	21:30	GlobeNewswire Inc.	Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing	NASDAQ:WVE	Wave Life Sciences Ltd
2024/03/27	21:30	GlobeNewswire Inc.	Wave Life Sciences to Present at Upcoming Investor Conferences	NASDAQ:WVE	Wave Life Sciences Ltd
2024/03/06	21:55	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:WVE	Wave Life Sciences Ltd
2024/03/06	21:39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WVE	Wave Life Sciences Ltd
2024/03/06	21:30	GlobeNewswire Inc.	Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:WVE	Wave Life Sciences Ltd
2024/02/28	22:30	GlobeNewswire Inc.	Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024	NASDAQ:WVE	Wave Life Sciences Ltd
2024/02/27	22:30	GlobeNewswire Inc.	Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular Dystrophy	NASDAQ:WVE	Wave Life Sciences Ltd
2024/02/13	06:15	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:WVE	Wave Life Sciences Ltd
2024/02/08	09:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:WVE	Wave Life Sciences Ltd
2024/02/08	09:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:WVE	Wave Life Sciences Ltd
2024/02/08	09:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:WVE	Wave Life Sciences Ltd
2024/02/08	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:WVE	Wave Life Sciences Ltd
2024/01/08	22:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WVE	Wave Life Sciences Ltd
2024/01/08	22:00	GlobeNewswire Inc.	Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 Milestones	NASDAQ:WVE	Wave Life Sciences Ltd
2024/01/05	06:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WVE	Wave Life Sciences Ltd
2024/01/03	22:30	GlobeNewswire Inc.	Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:WVE	Wave Life Sciences Ltd
2023/12/15	22:36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WVE	Wave Life Sciences Ltd
2023/12/15	22:30	GlobeNewswire Inc.	Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenne Muscular Dystrophy	NASDAQ:WVE	Wave Life Sciences Ltd
2023/12/08	20:06	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:WVE	Wave Life Sciences Ltd
2023/12/08	11:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WVE	Wave Life Sciences Ltd